Why Biomedical Data Infrastructure Matters in 2026

Every clinical trial, every public health surveillance effort, and every drug approval decision in the United States depends on something most patients never think about: the biomedical data infrastructure quietly running behind the scenes. In 2026, biomedical data infrastructure is receiving unusual public attention—not because it is thriving, but because researchers are warning that it is fragile.

At a recent industry panel, biomedical researchers sounded an alarm that the publicly funded data infrastructure underpinning virtually all of modern biomedical research is fragile, underfunded, and increasingly at risk. Panelists pointed to a period when federal funding was abruptly cut to research institutions, leaving researchers idle, and roughly 30% of public health datasets hosted on a major federal health website were taken down—some never restored. The resources researchers said their work depended on most included a familiar list: genomic and phenotype databases, cancer genome atlases, gene expression repositories, biomedical literature databases, clinical trial registries, and chemical and protein structure databases.

At the same time, 2026 has also brought major infrastructure investment. A leading NIH research program recently issued its most expansive data release ever, making genomic and electronic health record data from more than 747,000 participants available to registered researchers at no cost. This tension—between infrastructure that is expanding in some areas and eroding in others—is exactly why understanding biomedical data infrastructure, and the professionals who build and maintain it, matters so much right now.

What Biomedical Data Infrastructure Actually Means

Defining the Term

Biomedical data infrastructure refers to the interconnected systems, standards, repositories, and governance frameworks that allow researchers to collect, store, share, and analyze health-related data across studies, institutions, and time. This includes clinical trial databases, electronic health record systems, genomic and biospecimen repositories, cloud computing platforms, data standards like CDISC and FHIR, and the identity and access management tools that let qualified researchers connect to and use these resources.

The National Institutes of Health describes a highly efficient and effective biomedical research data infrastructure as critical to its core mission of translating research knowledge into improved health outcomes. NIH is actively pursuing cloud partnerships with academic institutions and industry to support secure data storage and broad research access, while building shared identity and access tools that allow scientists to connect across multiple NIH data platforms and resources.

Why It Underpins Clinical Trials, Public Health, and Medical Innovation

Public biomedical databases have become an essential resource across four broad categories: public health databases, clinical databases, comprehensive cohort databases, and omics databases covering genomic, proteomic, and related molecular data. These resources support population health monitoring, clinical research design, predictive modeling, and biomarker discovery—work that would be effectively impossible without shared, accessible, well-organized data systems.

Cancer research offers a clear illustration. A federally sponsored data commons initiative connects cancer genomic, clinical, and imaging data across multiple linked platforms, enabling researchers nationwide to query and analyze data that no single institution could generate on its own. Similarly, national coordinating centers for conditions like Alzheimer’s disease consolidate clinical, neuroimaging, biomarker, and genetic data from research center networks into single, harmonized resources that extramural investigators can request access to for their own studies. Without this kind of shared infrastructure, biomedical research would be reduced to disconnected, duplicative efforts—slower, more expensive, and far less likely to produce patient-relevant breakthroughs.

The Core Challenges Facing Biomedical Data Systems Today

Fragmentation and Data Silos

Despite growing investment, fragmentation remains one of the most persistent problems in biomedical data infrastructure. Health data are frequently trapped in disconnected systems—individual hospital electronic health records, isolated laboratory information systems, and siloed clinical trial databases that were never designed to communicate with each other. A recent cross-institutional survey of biomedical informatics priorities found consistent, convergent demand across institutions for multi-modal data integration, secure standardized access methods, and infrastructure capable of training analytical models without retaining personally identifiable information—demand that reflects just how unresolved the fragmentation problem remains.

Outdated Systems and Poor Interoperability

Interoperability—the ability of different systems to exchange and meaningfully use data—continues to be a major barrier. Clinical systems typically collect and share healthcare data using HL7 FHIR standards, while clinical trial data submitted to regulators must conform to CDISC standards; these two data worlds do not translate to each other automatically, requiring dedicated mapping efforts between formats. Even with joint implementation guides now mapping FHIR resources to CDISC data domains such as adverse events, medical history, and laboratory results, this translation work remains a technical and resource-intensive undertaking for many research organizations.

Data Quality, Security Risks, and Limited Research Access

Legacy data conversion presents its own quality risks. When older or non-standardized datasets are converted into modern formats for regulatory submission, sponsors must document a formal legacy data conversion plan and report, describing issues encountered and resolved during the process—an explicit regulatory acknowledgment that data quality can be compromised during system transitions. Beyond quality, funding instability introduces genuine security and access risks: infrastructure funded through short-term, competitive grants rather than stable appropriations is vulnerable to sudden disruption, as demonstrated when a significant share of public health datasets was taken offline during a recent funding disruption, limiting research access for the scientific community relying on that data.

The table below summarizes the primary challenges and their consequences for clinical research.

Challenge	Description	Research Impact
Data fragmentation	Health data isolated across disconnected EHRs, labs, and trial systems	Slower analysis, duplicated effort, incomplete patient pictures
Interoperability gaps	FHIR-based clinical data and CDISC-based trial data require complex mapping	Added time and cost to prepare data for regulatory submission
Legacy data quality issues	Older datasets require conversion and validation for modern use	Risk of traceability and accuracy issues during conversion
Unstable public funding	Critical repositories funded through competitive annual grants	Sudden loss of access to essential public datasets
Limited access infrastructure	Inconsistent identity and access management across data platforms	Barriers for researchers, especially at smaller institutions

How Stronger Data Systems Improve Clinical Research

Speed, Accuracy, and Collaboration

When data infrastructure works well, the benefits are substantial and measurable. NIH’s 2025-2030 Strategic Plan for Data Science outlines a goal of supporting a federated biomedical research data infrastructure—explicitly framed as a solution for researchers “tired of data silos”—that would let scientists more easily connect disparate datasets across major platforms through a shared cloud interoperability program. This kind of federation reduces duplicated data preparation work, accelerates the pace at which researchers can test hypotheses, and improves accuracy by allowing cross-validation across multiple independent data sources.

Collaboration also improves dramatically when infrastructure is standardized and accessible. NIH’s expanded genomic and electronic health record database gives scientists at rural and smaller universities the same data access as researchers at major research institutions, available through a cloud-based researcher workbench at no cost. This kind of equitable access can meaningfully broaden the pool of researchers contributing to biomedical discovery, rather than concentrating research capacity only among institutions that can afford to build proprietary data systems.

Regulatory Reporting and Compliance Benefits

Standardized data infrastructure also directly supports regulatory reporting and compliance. The FDA requires that clinical trial data submitted in support of drug and biologic approvals conform to CDISC standards, including the Study Data Tabulation Model (SDTM) for tabulation and Analysis Data Model (ADaM) for analysis datasets. Organizations that build consistent, standards-based data infrastructure from the start of a trial—rather than converting non-standardized data at the end—experience fewer traceability issues, cleaner submission packages, and generally smoother regulatory review.

Federal harmonization efforts illustrate the scale of this challenge and its potential payoff: one cross-agency initiative is working to harmonize roughly 12 petabytes of biomedical data collected over 70 years, laying the groundwork for more consistent, AI-ready health research infrastructure at the national level. Efforts like this demonstrate that strong data systems are not simply a technical convenience—they are a foundational requirement for faster, more reliable, and more defensible research and regulatory decision-making.

Data Standards, FDA Submission, and Patient Protection

Data standards are the connective tissue that make biomedical data infrastructure trustworthy and usable across institutions. CDISC standards—including Controlled Terminology, SDTM, ADaM, SEND for nonclinical studies, and Define-XML—are formally required by the FDA for regulatory submissions, and additional CDISC Therapeutic Area Standards are updated periodically through the FDA’s Study Data Technical Conformance Guide. These standards ensure that data submitted to support a new drug or device is structured consistently enough for regulators to review efficiently and compare across submissions.

Beyond regulatory efficiency, strong data infrastructure has a direct connection to patient protection. Complete, well-organized, and properly validated clinical trial data allows regulators to thoroughly evaluate safety and efficacy before a product reaches patients, and it allows researchers to trace exactly how legacy or converted data was derived if questions arise during review. The FDA continues to evaluate emerging data exchange formats, including testing of newer message standards intended to replace older file formats for regulatory data submission, reflecting an ongoing commitment to modernizing these safeguards as technology evolves.

Career Impact: Growing Demand for Biomedical Data Professionals

A Fast-Growing, High-Demand Field

The professionals who build, maintain, and govern biomedical data infrastructure are in significant demand across the United States in 2026. Bioinformatics and computational biology roles in life sciences are projected to grow significantly faster than average occupational growth, driven by the explosion of multi-omics data, AI integration, and expanding precision medicine programs. Recent job market analysis found average bioinformatics salaries in the $136,000 to $215,000 range in early 2026, with continued quarter-over-quarter growth in both hiring volume and compensation transparency.

Demand extends well beyond core bioinformatics roles. As biomedical data infrastructure becomes more central to research operations, organizations are hiring across a broader spectrum of data-focused clinical and research roles—reflecting a shift where data literacy and systems thinking are becoming baseline expectations rather than specialized add-ons.

Key Roles Supporting Biomedical Data Infrastructure

Professionals contributing to this field include:

• Clinical Data Manager: Oversees the accuracy, completeness, and standards compliance of clinical trial data, ensuring datasets meet CDISC requirements for regulatory submission.
• Bioinformatics Specialist: Builds and maintains data pipelines for genomic, transcriptomic, and other omics data, applying computational methods to support drug discovery and biomarker research.
• Healthcare Data Analyst: Analyzes structured clinical and health system data to support research questions, quality reporting, and outcomes analysis across research and operational settings.
• Clinical Research Associate (CRA): Monitors clinical trial sites, verifies data quality and protocol adherence, and increasingly interacts with standardized data systems and reporting tools.
• Clinical Trial Coordinator: Supports day-to-day data collection activities at the site level and helps ensure information is captured accurately for integration into broader trial databases.
• Data Governance Specialist: Establishes and enforces policies for data access, security, quality, and standards compliance across research data systems.
• Clinical Operations Specialist: Coordinates across research teams to ensure data infrastructure supports operational needs, from site activation to regulatory reporting timelines.
• Research Informatics Specialist: Designs and manages the technical systems—databases, interoperability tools, and cloud platforms—that connect clinical and research data across an organization.

Skills That Set Candidates Apart

Professionals building careers in this space benefit from developing several specific competencies:

• Understanding of core data standards, including CDISC (SDTM, ADaM, Define-XML) and HL7 FHIR, and how they relate to each other in clinical and research contexts.
• Familiarity with cloud-based research computing platforms and federated data access models.
• Experience with data quality validation, legacy data conversion, and audit-trail documentation practices.
• Knowledge of data governance principles, including privacy-preserving analytics and secure, standardized access controls.
• Comfort working across multidisciplinary teams that include clinicians, statisticians, regulatory affairs staff, and IT professionals.

Practical Takeaways for Data Professionals and Research Organizations

For current clinical data and bioinformatics professionals:

• Build fluency in both FHIR and CDISC standards. As clinical and research data systems increasingly need to communicate with each other, professionals comfortable navigating both frameworks are especially valuable.
• Get involved in data governance conversations early. Organizations are increasingly prioritizing privacy-preserving, federated data infrastructure, and professionals who understand these principles are well positioned for leadership roles.
• Stay current on FDA data standards updates. The FDA periodically updates its Study Data Technical Conformance Guide and evaluates new submission formats, and staying current directly supports smoother regulatory submissions.

For clinical job seekers entering biomedical data careers:

• Highlight any coursework or hands-on experience with clinical databases, bioinformatics pipelines, or health data standards on your resume.
• Consider building practical experience with cloud computing platforms, as federated and cloud-based research infrastructure is rapidly becoming the industry standard.
• Look for opportunities at academic medical centers, government research agencies, and biotech or pharma organizations actively investing in modernized data infrastructure.

For research organizations and data teams:

• Invest in standards-based infrastructure from the start of a study, rather than retrofitting legacy data later, to reduce quality risks and submission delays.
• Build redundancy into data access planning. Recent disruptions to public data resources underscore the importance of institutional data management strategies that do not rely solely on external repositories remaining continuously available.

Conclusion

Biomedical data infrastructure is not a background technical detail—it is the foundation that determines how quickly, accurately, and safely clinical research can move from question to answer. The challenges are real: fragmentation, interoperability gaps, funding instability, and data quality risks all continue to slow research and, in some cases, threaten access to resources the scientific community depends on. At the same time, meaningful progress is underway, from expanded federal data releases to new standards mapping efforts designed to make research data more connected and usable than ever before.

For Clinical Data Managers, Bioinformatics Specialists, Healthcare Data Analysts, Clinical Research Associates, Clinical Trial Coordinators, Data Governance Specialists, Clinical Operations Specialists, and Research Informatics Specialists, this is a moment of real opportunity. Professionals who understand both the technical and regulatory dimensions of biomedical data infrastructure will be essential to building a research ecosystem that is faster, more collaborative, and more resilient in the years ahead.

In the coming decade, organizations that invest early in resilient biomedical data infrastructure will be the ones trusted to run complex, data‑intensive clinical research.

Call to Action

Strong biomedical data infrastructure depends on skilled, forward-thinking professionals.

Search clinical jobs in clinical data management, bioinformatics, research informatics, and data governance across the United States.
Upload your resume to connect with research institutions, pharma companies, and health systems investing in modern biomedical data infrastructure.
Apply now for Clinical Data Manager, Bioinformatics Specialist, Healthcare Data Analyst, and Research Informatics Specialist roles shaping the future of clinical research.

FAQ

Follow us on Social Media: LinkedIn | Facebook | Twitter | Instagram